MRI guided Focused Ultrasound

Slides:



Advertisements
Similar presentations
DR.RAVINDRA SRIVASTAVA, CONSULTANT NEUROSURGEON VIMHANS HOSPITAL.NEW DELHI.
Advertisements

Leslie Cloud, MD Department of Neurology Division of Movement Disorders Emory University School of Medicine.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Introduction Recent guidelines considered PCI to be a potential alternative to CABG for ULMCA stenosis, based on several large registries and randomized.
Parkinson’s Disease (PD)
By Lisa Rosenberg Deep Brain Stimulation. Electrical probe implanted in brain Approved by FDA in mid 1990’s Hidden under skin Does not damage healthy.
Shabalov V 1,Tomskiy A 1, Gamaleya A 1,2, Orlova O 3, Timerbaeva S 4, Isagulyan E 1, Dekopov A 1, Salova E 1, Fedorova N 2 1 Functional Neurosurgery Group,
MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.
Can we prevent stent restenosis after coronary stent implantation
ARTIFICIAL DISC VERSUS FUSION A prospective randomised study with 2-year follow-up on 99 patients.
Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter Aortic Valve Replacement Raghavendra Paknikar BS Jeffrey Friedman BS David.
Surgery For Parkinson’s Disease Current Practice and Future Directions
Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical.
Epilepsy Surgery Matthew A. Howard III MD Professor and Chairman Department of Neurosurgery University of Iowa.
JAHDIEL FRANCO BME 482 Deep Brain Stimulation for Psychiatric Disorders.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
Physical Therapy A Guide for Aspiring College Students Created by: Kyle Norman.
Deep Brain Stimulation For parkinson’s disease
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
Overview of Neurostimulation
Enhanced MR guided Focused Ultrasound Surgery (MRgFUS) Guidelines Demonstrates Improved Efficacy and Durability for the Treatment of Uterine Myoma Phyllis.
Medical Imaging Technology
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
International Survey on Management of Paediatric Ependymomas: Preliminary Results Guirish Solanki ¥, G Narenthiran § Department of Neurosurgery ¥ Birmingham.
Multimedia Health Education Can It Change Clinical Practice? Assoc Prof Leo Donnan Director of Orthopaedics Chief of Surgery RCH.
Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Univ logo Repetitive Control Based Tremor Suppression Using Electrical Stimulation Engin Hasan Copur Dr. Bing Chu, Dr. Christopher Freeman, Dr. Dina Shona.
Technical Aspects of Percutaneous Vertebroplasty Dr. Cosme Argerich Neurosurgeon.
Deep Brain Stimulation (DBS) Ramin AmirNovin, MD LDR Neurosurgery and Associates.
Focused Ultrasound Neuromodulation of the Hypothalamus Alexander Korb, Ph.D. Mentor: Alexander Bystritsky, M.D., Ph.D.
1 Overview of Gamma Knife ® Surgery Dr. Sandra Vermeulen, M.D. Swedish Cancer Institute Northwest Hospital Gamma Knife Center Seattle, Washington Learn.
Treatment of Essential Tremor with Stereotactic Radiosurgery
Aaron Mulheren, Kathryn Wilson, MSN, APN, Milind Deogaonkar, MD
The Effects of Deep Brain Stimulation on the Motor Symptoms of Parkinson’s Disease Aaron Mulheren Kathryn Wilson, MSN, APN Milind Deogaonkar, MD Science.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Placebo-Controls in Short-Term Clinical Trials of Hypertension Sana Al-Khatib, MD, MHS Assistant Professor of Medicine Division of Cardiology Duke University.
ACCELEROMETRY DURING ABLATIVE THALAMIC SURGERY FOR PARKINSONIAN TREMOR Authors: J. Ciurea V. Nestianu*, Ileana Simoca, Dept. of Neurosurgery, University.
Electroconvulsive Therapy Review the outline in notes.
Parkinson’s Disease by Jessica Teen Health 8 Definition *Parkinson’s Disease is a disorder of the brain characterized by shaking and having difficulty.
Quantitative Detection of Parkinson's Disease Symptoms Advisor: Dr. Chris Kao Project Team: Kylen Bares Eddie Cao.
NYU Medical Grand Rounds Clinical Vignette Rachel Shur PGY-2 October 16, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Brigham and Women’s Hospital, Department of Radiology
Note: this Live Meeting is being recorded By participating in this meeting, you agree that your communications may be recorded, including Q & A that may.
Adverse Outcomes After Hospitalization and Delirium in Persons with Alzheimer Disease Charles Wang, PharmD Candidate.
CARDIOLOGIA INV 1 CAREGGI - FIRENZE Objective To determine whether nonresponsiveness to clopidogrel as revealed by high in vitro residual platelet reactivity.
John T. Wilkinson m. d. , Chad E. Songy m. d. , Frances l
AP PSYCHOLOGY: UNIT II Introductory Psychology: Biological Bases of Behavior Topic: Research Methods.
Case 1….. A patient delays initiation of movement, displays an uneven trajectory in moving her hand from above her head to touch her nose, and is uneven.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Parkinson’s Test Device Development Tiffany Feltman Erin Sikkel.
Deep Brain Stimulation Surgery in India. Deep Brain Stimulation can help to treat with many symptoms caused by the following movement disorders: Parkinson’s.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
Case presentation in normal pressure hydrocephalus 中國醫藥大學附設醫院神經部 楊玉婉.
THE IMPLEMENTATION OF ABLATIVE HYPOFRACTIONATED RADIOTHERAPY FOR STEREOTACTIC TREATMENTS IN THE BRAIN AND BODY: OBSERVATIONS ON EFFICACY AND TOXICITY IN.
Journal Club Neuropsychological effects of levetiracetam and carbamazepine in children with focal epilepsy. Rebecca Luke 2/9/2016.
The Placebo Response and Effect  Can be significant  30% or more in certain interventions  An individual’s overall disease manifestation and treatment.
SANTE: Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy Professor Ley Sander MD PhD FRCP.
Deep Brain Stimulation: A Proven Treatment for Movement Disorders
WORLD FEDERATION OF NEUROSCIENCE NURSES
Parkinson’s disease.
ATHENA Trial Presented at Heart Rhythm 2008 in San Francisco, USA
Re-irradiation with VMAT for progressive brain metastases after previous whole brain radiation for radionecrosis risk avoidance. Marilena Theodorou, MD.
TRANSPORT2 - Eligibility -
Atlantic Cardiovascular Patient Outcomes Research Team
Deep Brain Stimulation: What, When, Why, How
T2 weighted magnetic resonance image (MRI) scan of 28 year old woman with complex partial seizures but no focal neurological deficit. T2 weighted magnetic.
Presentation transcript:

MRI guided Focused Ultrasound (MRgFUS) for essential tremor Michael L. Schwartz, MD, MSc, FRCSC, Neurosurgeon, Professor of Surgery, University of Toronto, m.schwartz@utoronto.ca

The development of MRgFUS has been motivated by the desire to develop less invasive functional neurosurgery

Essential Tremor Background The most common movement disorder Prevalence 0.4 – 5% Essential tremor features Postural (with maintenance of a position) or Kinetic (during voluntary movement) Often familial Often disabling: 15 – 25% retire early, 60% do not apply for promotion May respond to ethanol, primidone, propranolol but often progressive with medication failing and ~1/3 abandoning medication Surgery may be offered to patients with disabling, medication-resistant tremor

Leksell Stereotactic Arc and Frame Movement disorder surgery started to become very common around the world…thanks to the standardization of the procedure The huge advantage is the uniformity of it, and how it standardized the procedure, so surgeons around the world can do the same procedure in the same way. Leksell in action, and it was transported around the world, including to Toronto. Indeed, even today, surgeons in Toronto, ad surgeons in New York, and surgeons in Shanghai perform DBS in more or less a similar fashion. Prof. Lars Leksell Karolinska Institute 1960s Prof. Ronald Tasker, University of Toronto 1960s Leksell Stereotactic Arc and Frame 1949

RF thalamotomy circa 1974 No cross-sectional imaging! Air and iodinated contrast in the ventricles to measure the AC-PC line and see the top of the thalamus. Computer generated “operative template” customizing the S&B atlas. Stimulation mapping to correct for distortions. “…somatosensory data plotted exactly where obtained, fall over the expected location of Vim, 5mm rostral to where they would have been expected from radiological localization of the anterior and posterior commissures.”

Surgical Treatment with DBS Ann neurol 1997;42:292-299

MRI guided Focused Ultrasound (MRgFUS) http://www.insightec.com/contentManagment/uploadedFiles/fileGallery/transcranial_mrgfus_white_paper.pdf

MRI guided Focused Ultrasound (MRgFUS) hemispheric array of 1024 transducers rubber diaphragm cold water circulation transducer array

MRI guided Focused Ultrasound (MRgFUS) Heat maps measured by MRI Heating at the focal point: temporal progression oC Heat maps measured by MRI Parallel to the axis of the beam Perpendicular to the axis of the beam 6 s 13 s 20 s 27 s sonication cooling

MRgFUS Inclusion criteria Age between 18-80 years and able to consent Diagnosis of essential tremor by movement disorder neurologist Tremor refractory to medication: adequate dose or side effects (propranolol, primidone) Stable doses of medication for 30 days prior to treatment Able to communicate during the procedure Clinical Rating Sale for Tremor (CRST) postural or intention tremor = or > 2 (tremor amplitude in cm) disability subsection score = or > 2 (unable to bring food to mouth with one hand = 3)

MRgFUS Exclusion criteria Standard MRI contraindications (pacemaker, size limitations) Allergy to MRI contrast material Inability to lie still or communicate during the procedure Cardiovascular instability (angina, recent infarct, heart failure, hypertension) Cerebrovascular disease (recent stroke) Presence of other neurodegenerative diseases (Parkinson’s +, PSP etc.) Brain tumors Recent seizures (<1yr) Unstable psychiatric disease or cognitive impairment (MMS < 25) Pregnancy or lactation Bleeding disorders Previous DBS or thalamotomy

MRgFUS Study Methods All patients were awake during the procedure and were examined after each sonication. Average of 22.5 sonications across the 4 patients. Nucleus ventralis intermedius was the target One patient reported tingling and numbness at the corner of the mouth and in the index finger at temperatures below 50oC.

Nucleus ventralis intermedius (Vim) Patient 4 October 2012

Patient 4 October 2012

Magnetic Resonance Imaging Guidance Thermal imaging Thermal feedback every 3 to 5 seconds Showing temperature at the focus of sonication

Patient 2 July 2012

Post-treatment Imaging Day 30 Day 1 Day 90 Patient 2 Day 7

CRST (B) pre post

Clinical Rating Scale for Tremor (CRST) Vertical lines are standard deviation around the mean

Mean tremor scores for the dominant (treated arm) only Vertical lines are standard deviation around the mean

Total CRST = Total score on Clinical Rating Scale for Tremor CRST A Dom = Tremor score for dominant (treated) hand only CRST B Dom = Objective disability score on gross and fine motor tasks using the dominant (treated) hand CRST C = Subjective disability secondary to tremor Vertical lines are standard deviation around the mean

Significant improvements in subjective and objective disability. Summary of Results Five patients followed to 3 months All Male, average age 70 (4 Right hand dominant, 1 Left hand dominant) Average duration of illness 17 years All patients trying and failing multiple medications and followed by movement disorder neurologist At 1-month post-op: average 91.5% reduction in tremor score of dominant (treated) arm At 3-months post-op: average 85% reduction Adverse events: numbness in thumb/finger of treated arm (resolved in one and persistent in another patient), gait unsteadiness (resolved) Pre-treatment: all patients unable to write, feed themselves, or dress themselves Significant improvements in subjective and objective disability. All patients able to write, drink from a cup and eat unassisted at 3-months follow-up

Conclusion MRgFUS may offer a non-invasive alternative to standard neurosurgical techniques. The sample is very small but we have treated six patients safely and effectively. From a radiographic perspective, the lesions are indistinguishable from those made by the standard RF method. The treatment has produced a lasting reduction in the tremor of six patients.  

A patient’s story